BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of EUR10.77, EUR1.86 better than the analyst estimate of EUR8.91. Revenue for the quarter came in at EUR5.31 billion versus the consensus estimate of EUR3.84 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.